Shire Plc is considering a new offer from Takeda Pharmaceutical Co. after the Japanese drugmaker revised its roughly $60 billion bid for the biotechnology company once again.
- Trump says he invoked 5th Amendment in deposition for New York investigation
- Kaboom averted
- Inflation comes off 40-year high but stays elevated at 8.5% as gas prices fall but food, rent jump, CPI report shows
- Youth take part in annual beach patrol competition
- Meet the jurors in the Whitmer kidnap retrial — most don’t like the news